In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist

Cilt: 15 Sayı: 2 15 Ocak 2013
  • Trivendra Tripathi
  • Mohammad Shahid
  • Adil Raza
  • Haris M. Khan
  • Mashiatullah Siddiqui
  • Abida Malik
  • Rahat Ali Khan
PDF İndir
EN

In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist

Abstract

Abstract. Accumulating evidences have highlighted histamine and histamine receptors (HRs)-antagonists’ role in immunomodulation. However, the roles of HRs-agonists are still unclear. The present study was therefore designed to delineate the comparative immunotoxic roles of H1-H4-agonist on antibody generation profile in rabbit model. The cohort comprised of seven groups (Group-I negative control, group-II positive control and group-III-VII HRs-agonist-treated) containing 18 (9 male and 9 female) rabbits each. Group-I and group-II received vehicle (sterile distilled water, 1mlkg-1×b.i.d.) intramuscularly. Groups-III-VII (HRs-agonist-treated) received subcutaneous histamine (100µgkg-1) and H1-agonist (HTMT), H2-agonist (amthamine), H3-agonist (R-[-]-α-methylhistamine) and H4-agonist (clobenpropit) each in a dose of 10µgkg-1, respectively, b.i.d. for 10 days (starting from day 1). Groups-II-VII were subsequently immunized with intravenous injection of SRBC at day 3. The estimation of serum immunoglobulins (Ig), IgM and IgG were done by ELISA, and observed at day 0 (pre-immunization) and day 7, 14, 21, 28 and 58 (post-immunization). Results showed that histamine and HRs-agonist could influence a detectable antibody response to SRBC as early as day 7-postimmunization (post-I), which lasted until day 58- post-I. All the results were found statistically significant (p<0.05). To conclude, our results provide evidences that HTMT, amthamine and clobenpropit (H1-, H2- and H4-agonist, respectively) have important role in modulation of antibody generation by enhancing production level, in which HTMT have dominant role, while amthamine and clobenpropit play similar role. Conversely, R-[-]-α-methylhistamine (H3-agonist) have dominant inhibitory role on antibody production.

Key words: Histamine, histamine receptors, agonists, immunomodulation, antibody generation, immunotoxic

Keywords

Kaynakça

  1. Shahid M, Tripathi T, Sobia F, et al. Histamine, histamine receptors, and their role in immunomodulation: an updated systematic review. Open Immunol J 2009; 2: 9-41.
  2. Falus A, Hargita H, Eszter L, et al. Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation. Trends Immunol 2001; 22: 648-652.
  3. Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nature Rev Drug Dis 2008; 7: 41-53.
  4. Huang JF, Thurmond RL. The New Biology of Histamine Receptors. Curr Allergy Asthma Rep 2008; 8: 21-27.
  5. Ma RZ, Gao J, Meeker ND, et al. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 2002; 297: 620-623.
  6. Quintana FJ, Buzas E, Prohászka Z, et al. Knock-out of the histidine decarboxylase gene modifies the repertoire of natural autoantibodies. J Autoimmun 2004; 22: 297-305.
  7. Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001; 413: 420-425.
  8. Lim HD, van Rijn RM, Ling P, et al. Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist. J Pharmacol Exp Ther 2005; 314: 1310-1321.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Trivendra Tripathi Bu kişi benim

Mohammad Shahid Bu kişi benim

Haris M. Khan Bu kişi benim

Mashiatullah Siddiqui Bu kişi benim

Abida Malik Bu kişi benim

Rahat Ali Khan Bu kişi benim

Yayımlanma Tarihi

15 Ocak 2013

Gönderilme Tarihi

15 Ocak 2013

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2010 Cilt: 15 Sayı: 2

Kaynak Göster

APA
Tripathi, T., Shahid, M., Raza, A., Khan, H. M., Siddiqui, M., Malik, A., & Khan, R. A. (2013). In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist. EASTERN JOURNAL OF MEDICINE, 15(2), 48-56. https://izlik.org/JA59NR83CR
AMA
1.Tripathi T, Shahid M, Raza A, vd. In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist. EASTERN JOURNAL OF MEDICINE. 2013;15(2):48-56. https://izlik.org/JA59NR83CR
Chicago
Tripathi, Trivendra, Mohammad Shahid, Adil Raza, vd. 2013. “In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist”. EASTERN JOURNAL OF MEDICINE 15 (2): 48-56. https://izlik.org/JA59NR83CR.
EndNote
Tripathi T, Shahid M, Raza A, Khan HM, Siddiqui M, Malik A, Khan RA (01 Mart 2013) In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist. EASTERN JOURNAL OF MEDICINE 15 2 48–56.
IEEE
[1]T. Tripathi vd., “In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist”, EASTERN JOURNAL OF MEDICINE, c. 15, sy 2, ss. 48–56, Mar. 2013, [çevrimiçi]. Erişim adresi: https://izlik.org/JA59NR83CR
ISNAD
Tripathi, Trivendra - Shahid, Mohammad - Raza, Adil - Khan, Haris M. - Siddiqui, Mashiatullah - Malik, Abida - Khan, Rahat Ali. “In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist”. EASTERN JOURNAL OF MEDICINE 15/2 (01 Mart 2013): 48-56. https://izlik.org/JA59NR83CR.
JAMA
1.Tripathi T, Shahid M, Raza A, Khan HM, Siddiqui M, Malik A, Khan RA. In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist. EASTERN JOURNAL OF MEDICINE. 2013;15:48–56.
MLA
Tripathi, Trivendra, vd. “In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist”. EASTERN JOURNAL OF MEDICINE, c. 15, sy 2, Mart 2013, ss. 48-56, https://izlik.org/JA59NR83CR.
Vancouver
1.Trivendra Tripathi, Mohammad Shahid, Adil Raza, Haris M. Khan, Mashiatullah Siddiqui, Abida Malik, Rahat Ali Khan. In vivo comparative immunotoxic study of histamine receptors (H1R, H2R, H3R and H4R)-agonist. EASTERN JOURNAL OF MEDICINE [Internet]. 01 Mart 2013;15(2):48-56. Erişim adresi: https://izlik.org/JA59NR83CR